Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Moreno

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Pediatric Blood & Cancer|August 25, 2016
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trialsLucas Moreno, Herve Rubie, Amalia Varo, et al.
Allergologia Et Immunopathologia|March 15, 2025
A Delphi consensus on diagnosis, management, and treatment with allergen immunotherapy of polysensitized children in Spain: CAPP study, Part 1María Mesa-Del-Castillo, Francisco J Canals Candela, Ana Martínez-Cañavate, et al.
Pediatric Blood & Cancer|January 17, 2026
Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post-Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk GroupRebecca J Deyell, Kavitha Srivatsa, Paola Angelini, et al.
Expert Opinion on Drug Discovery|November 22, 2021
Methodological advances in the discovery of novel neuroblastoma therapeuticsMiguel F Segura, Aroa Soriano, Josep Roma, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2013
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experienceDaniel A Morgenstern, Darren Hargrave, Lynley V Marshall, et al.
European Radiology|March 17, 2015
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyKeiko Miyazaki, Neil P Jerome, David J Collins, et al.
Pediatric Blood & Cancer|September 13, 2016
Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomasFernando Carceller, Neil P Jerome, Keiko Miyazaki, et al.
European Radiology|March 23, 2016
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohortNeil P Jerome, Keiko Miyazaki, David J Collins, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Pediatric Blood & Cancer|August 25, 2016
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trialsLucas Moreno, Herve Rubie, Amalia Varo, et al.
Allergologia Et Immunopathologia|March 15, 2025
A Delphi consensus on diagnosis, management, and treatment with allergen immunotherapy of polysensitized children in Spain: CAPP study, Part 1María Mesa-Del-Castillo, Francisco J Canals Candela, Ana Martínez-Cañavate, et al.
Pediatric Blood & Cancer|January 17, 2026
Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post-Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk GroupRebecca J Deyell, Kavitha Srivatsa, Paola Angelini, et al.
Expert Opinion on Drug Discovery|November 22, 2021
Methodological advances in the discovery of novel neuroblastoma therapeuticsMiguel F Segura, Aroa Soriano, Josep Roma, et al.
Journal of Pediatric Hematology/Oncology|December 11, 2013
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experienceDaniel A Morgenstern, Darren Hargrave, Lynley V Marshall, et al.
European Radiology|March 17, 2015
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyKeiko Miyazaki, Neil P Jerome, David J Collins, et al.
Pediatric Blood & Cancer|September 13, 2016
Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomasFernando Carceller, Neil P Jerome, Keiko Miyazaki, et al.
European Radiology|March 23, 2016
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohortNeil P Jerome, Keiko Miyazaki, David J Collins, et al.
Pageof 13